Xtant Medical Holdings, Inc.
XTNT
$0.612
-$0.008-1.29%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 6,020.69% | 101.83% | 36.99% | -30.10% | 12.25% |
| Total Depreciation and Amortization | 8.85% | -6.45% | 6.99% | 7.52% | -0.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -38.14% | 39.92% | -30.29% | 13.20% | 18.46% |
| Change in Net Operating Assets | -194.47% | -201.81% | 184.19% | 114.06% | -2.75% |
| Cash from Operations | -0.16% | 92.18% | 138.71% | 66.23% | 11.59% |
| Capital Expenditure | 69.27% | -77.23% | 68.06% | -273.05% | 27.04% |
| Sale of Property, Plant, and Equipment | 2.08% | -54.29% | 10.53% | 13.10% | -15.15% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 72.27% | -101.59% | 71.78% | -318.54% | 28.78% |
| Total Debt Issued | 5.95% | -4.43% | -1.59% | -21.60% | 12.07% |
| Total Debt Repaid | 0.42% | 1.61% | -0.12% | 3.93% | -10.86% |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Common Stock | -477.78% | 86.76% | 26.88% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 55.88% | 94.78% | -205.85% | 443.58% | 58.94% |
| Cash from Financing | 172.03% | -7.61% | -116.07% | -17.41% | 24.23% |
| Foreign Exchange rate Adjustments | -850.00% | 98.17% | -619.05% | 275.00% | 75.51% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 303.82% | 9.13% | -153.79% | 88.29% | 165.74% |